
    
      This study takes "Rate of stone recurrence" as primary outcome measure, by random, blank
      control, and multicenter clinical trial design method, assess the efficacy and safety of
      potassium citrate extended-release tablets on Urolithiasis formation or recurrence, provide
      evidence for drug re-registration, and observe its efficacy on Urinary calculi such as renal
      tubular acidosis with calcium stone, and uric acid stones with or without calcium stone,
      urinary tract stone of effectiveness.
    
  